hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2024.217436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Xianghan Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affil…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Alternative Splicing, Pancreatic Neoplasms, Muscle Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer known for its high rate of early metastasis, necessitating the discovery of the underlying mechanisms. Herein, we report that heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) expression significantly increases at the invasion forefront in PDAC and is associated with early metastasis and poor prognosis. Our findings revealed that hnRNPLL knockdown resulted in extensive exon skipping (ES) events. In particular, we identified myoferlin (MYOF), a member of the ferlin family involved in membrane processes, as a functional splicing target of hnRNPLL. hnRNPLL depletion stimulates MYOF exon 17 retention to reduce the short isoform of MYOF (MYOFb) and inhibit metastasis. In contrast, hnRNPLL or MYOFb overexpression promoted pancreatic cancer cell migration and invasion. These results suggest that hnRNPLL is a critical factor for early PDAC metastasis. hnRNPLL and MYOFb may be potential therapeutic targets for PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China; State Ke…
- Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China; Gastroin…
- Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
- Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
- Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
- Shandong Provincial Key Laboratory of Clinical Research for Pancreatic Diseases, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China. Electron…
Zitieren
APA
Chen, X., Gong, R., Wang, L., Lei, K., Liu, X., Wang, J., Sun, M., Saluja, A. K., Yu, Q., & Ren, H. (2025). hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217436
Vancouver
Chen X, Gong R, Wang L, Lei K, Liu X, Wang J, et al. hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217436
BibTeX
@article{Chen2025,
author = {Chen, Xianghan and Gong, Ruining and Wang, Lili and Lei, Ke and Liu, Xiaolan and Wang, Jigang and Sun, Mingyue and Saluja, Ashok Kumar and Yu, Qian and Ren, He},
title = {hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2024.217436}
}
EUVIMED